Inc. stock despite strong Phase 2b data. Click for my updated look at MNMD stock and its market opportunities.
Many stocks don't offer particularly high yields. The stocks in the S&P 500, for instance, average a yield of just 1.3%. That ...
Federal student loans, Pell Grants not tied up in funding pause, but will be reviewed Best Cordless Chain Saws: Top-Rated ...
Jefferies analyst Akash Tewari adjusted the price target for Zentalis Pharmaceuticals (NASDAQ:ZNTL), bringing it down to $2.50 from the previous figure of $6.00, while reiterating a Hold rating on the ...
Oppenheimer made a significant adjustment to Zentalis Pharmaceuticals' (NASDAQ:ZNTL) price target, reducing it from $20.00 to ...
Michael Benkowitz, President and COO of United Therapeutics Corp (NASDAQ:UTHR), recently executed a series of stock ...
Ultragenyx Pharmaceutical is a mid-cap biotech firm with a promising pipeline and an optimistic outlook from analysts. Click ...
Kennedy seeks to be Secretary of Health and Human Services — a position that would put him in charge of the health of the ...
Ascendis Pharma boasts several commercial stage products. Read why ASND stock is an interesting speculative investment ...
A Pennsylvania-based pharmaceutical firm and the FDA issued a recall of an injectable blood pressure medicine after a customer noticed "a visible black particulate matter" in a vial. Dr. Bernard Ashby ...
PMGC Holdings Inc. (NASDAQ:ELAB), a pharmaceutical preparations company, announced on Monday that it has successfully completed transactions under a warrant inducement agreement, resulting in gross ...
BMO Capital Markets affirmed their positive stance on Novo Nordisk (NYSE:NVO) shares, maintaining an Outperform rating and a $105.00 price target. This confirmation followed the U.S. Food and Drug ...